N. Falgout

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

Kapil M. Patel, D. Sanders, R. Gibson, 2022, The Lancet. Respiratory medicine.

Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age.

J. Kolls, J. Shaffer, J. Schieffelin, 2022, medRxiv.